Vivoryon Therapeutics NV banner

Vivoryon Therapeutics NV
XETRA:05Y

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
XETRA:05Y
Watchlist
Price: 8.92 EUR 0.22% Market Closed
Market Cap: €196.7m

Wall St Price Targets

05Y Price Targets Summary
Vivoryon Therapeutics NV

Wall Street analysts forecast 05Y stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 05Y is 42.29 EUR with a low forecast of 35.89 EUR and a high forecast of 55.97 EUR.

Lowest Forecast
Price Target
35.89 EUR
302% Upside
Average Forecast
Price Target
42.29 EUR
374% Upside
Highest Forecast
Price Target
55.97 EUR
527% Upside
Vivoryon Therapeutics NV Competitors:
Price Targets
MASI
Masimo Corp
1% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 05Y's stock price target?
Price Target
42.29 EUR

According to Wall Street analysts, the average 1-year price target for 05Y is 42.29 EUR with a low forecast of 35.89 EUR and a high forecast of 55.97 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett